Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Adding Slow Release Tetracosactide Acetate to Eltrombopag Improves Haematological Response in ITP Patients with Platelet-Count Fluctuation

Francesco Iuliano, MD, Eleonora Iuliano, MD, Marco Rossi, MD

Blood (2018) 132 (Supplement 1): 2449.

https://doi.org/10.1182/blood-2018-99-118518

Published: 2018

Journal Articles

Assisted Administration of Subcutaneous Rituximab to the Patient's Home. Significant Reduction of Indirect Costs Incurred By Care Recipients and Unpaid Caregivers Together with a Total Adherence to the Treatment Schedule and Same Safety

Francesco Iuliano, MD, Eleonora Iuliano, MD, Marco Rossi, MD

Blood (2018) 132 (Supplement 1): 5869.

https://doi.org/10.1182/blood-2018-99-118756

Published: 2018

Journal Articles

Rituximab Subcutaneous Formulation (SC-R) Is Safe, Effective and Cost-Saving in Patients Suffering from Autoimmune Hemolytic Anemia (AIHA)

Francesco Iuliano, MD, Eleonora Iuliano, MD, Alessia Perricelli, MD, Angelo Pomillo, MD, Maria Luci, MD, Maria Aquila Santoro, MD, Pierosandro Tagliaferri, MD, Pierfrancesco Tassone, MD

Blood (2016) 128 (22): 1269.

https://doi.org/10.1182/blood.V128.22.1269.1269

Published: 2016

Journal Articles

Low Doses of Eltrombopag Are Safe and Effective in the Prophylaxis of the Chemotherapy-Induced Thrombocytopenia (CIT)

Francesco Iuliano, MD, Eleonora Iuliano, MD, Alessia Perricelli, MD, Maria Aquila Santoro, MD, Angelo Pomillo, MD, Maria Luci, MD, Pierosandro Tagliaferri, MD, Pierfrancesco Tassone, MD

Blood (2016) 128 (22): 4926.

https://doi.org/10.1182/blood.V128.22.4926.4926

Published: 2016

Journal Articles

Effectiveness and Safety of Low Dose Eltrombopag Twice Weekly in ITP Patients That Achieved CR after 50mg Daily Standard Dose

Francesco Iuliano, MD, Eleonora Iuliano, MD, Alessia Perricelli, MD, Angelo Pomillo, MD, Maria Luci, MD, Elisabetta Abruzzese

Blood (2014) 124 (21): 2788.

https://doi.org/10.1182/blood.V124.21.2788.2788

Published: 2014

Journal Articles

Subcutaneous Immunoglobulin (SCIG) in Responders to Intravenous Therapy with Chronic Immune Thrombocytopenia (ITP)

Francesco Iuliano, MD, Eleonora Iuliano, MD, Maria Luci, MD, Alessia Perricelli, MD, Angelo Pomillo, MD, Elisabetta Abruzzese

Blood (2014) 124 (21): 5012.

https://doi.org/10.1182/blood.V124.21.5012.5012

Published: 2014

Journal Articles

Assisted Administration Of Subcutaneous 5-Azacytidine to The Patient's Home. Significant Reduction Of Indirect Costs Incurred By Care Recipients and Unpaid Caregivers Together With a Total Adhesion To The Treatment Schedule and Same Safety

Francesco Iuliano, MD, Eleonora Iuliano, MD, Alessia Perricelli, MD, Angelo Pomillo, MD, Maria Luci, MD, Gianluca Cervo

Blood (2013) 122 (21): 5587.

https://doi.org/10.1182/blood.V122.21.5587.5587

Published: 2013

Journal Articles

Platelet Kinetic Study (PKS) May Early Identify a Subset of Patients with Immune Thrombocytopenia (ITP) Probably Cured by Romiplostim. Two Years Follow-up

Francesco Iuliano, MD, Alessia Perricelli, MD, Eleonora Iuliano, MD, Stefania Infusino, PhD, Angelo Pomillo, MD, Maria Luci, MD, Filippo Barbano, MD

Blood (2012) 120 (21): 1099.

https://doi.org/10.1182/blood.V120.21.1099.1099

Published: 2012

Journal Articles

Efficacy and Tolerability of Pregabalin in Decreasing Pain Associated with High Dose of Imatinib in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase CML.

Francesco Iuliano, MD, Massimo DI Maio, MD, Stefania Infusino, MD, Alessia Perricelli, MD, Angelo Pomillo, MD, Daniela Cilloni, MD, Giuseppe Saglio, MD

Blood (2007) 110 (11): 4570.

https://doi.org/10.1182/blood.V110.11.4570.4570

Published: 2007

Journal Articles

Phase II Study of Liposome Encapsulated Doxorubicin Citrate Complex, NPLD (Myocet™) in Myelofibrosis with Myeloid Metaplasia (MMM).

Francesco Iuliano, MD, Daniela Cilloni, MD, Molica Stefano, MD, Sterpone Paola, Di Maio Massimo, MD, Gottardi Enrico, Messa Emanuela, Serra Anna, Peta Antonio, MD

Blood (2006) 108 (11): 3621.

https://doi.org/10.1182/blood.V108.11.3621.3621

Published: 2006

Journal Articles

Correlation of JAK2 Mutation and PRV-1 and WT1 Transcript Amount in Myeloproliferative Disorders.

Anna Serra, PhD, Sonia Carturan, PhD, Enrico Gottardi, PhD, Francesca Arruga, PhD, Francesca Messa, PhD, Paola Sterpone, PhD, Ilaria Defilippi, PhD, Valentina Rosso, PhD, Renata Catalano, PhD, Giovanni Martinelli, MD, Francesco Iuliano, MD, Giuseppe Saglio, MD, Daniela Cilloni, MD, PhD

Blood (2005) 106 (11): 1206.

https://doi.org/10.1182/blood.V106.11.1206.1206

Published: 2005

Journal Articles

Successful Peripheral Blood Stem Cell (PBSC) Mobilisation with G-CSF in Patients with Chronic Myeloid Leukaemia Achieving Complete Cytogenetic Remission with Imatinib.

A.M. Carella, MD, Maria T. Corsetti, MD, Carlo Bodenizza, MD, Francesco Iuliano, MD, Giulia Pucci, MD, Pasquale Jacopino, MD, Bruno Martino, MD, Maura Brugiatelli, MD, Felicetto Ferrara, MD

Blood (2004) 104 (11): 4652.

https://doi.org/10.1182/blood.V104.11.4652.4652

Published: 2004

Journal Articles

WT-1 Over-Expression Could Be Related to " High Metaplastic Index" in Myelofibrosis with Myeloid Metaplasia (MMM) Patients. A Preliminary Report.

Francesco Iuliano, MD, Daniela Cilloni, MD, Enrico Gottardi, MD, Milena Fava, MD, Flora Fabiano, MD, Antonio Peta, MD, Giuseppe Saglio, MD

Blood (2004) 104 (11): 4761.

https://doi.org/10.1182/blood.V104.11.4761.4761

Published: 2004

NARROW

Adding Slow Release Tetracosactide Acetate to Eltrombopag Improves Haematological Response in ITP Patients with Platelet-Count Fluctuation

Assisted Administration of Subcutaneous Rituximab to the Patient's Home. Significant Reduction of Indirect Costs Incurred By Care Recipients and Unpaid Caregivers Together with a Total Adherence to the Treatment Schedule and Same Safety

Rituximab Subcutaneous Formulation (SC-R) Is Safe, Effective and Cost-Saving in Patients Suffering from Autoimmune Hemolytic Anemia (AIHA)

Low Doses of Eltrombopag Are Safe and Effective in the Prophylaxis of the Chemotherapy-Induced Thrombocytopenia (CIT)

Effectiveness and Safety of Low Dose Eltrombopag Twice Weekly in ITP Patients That Achieved CR after 50mg Daily Standard Dose

Subcutaneous Immunoglobulin (SCIG) in Responders to Intravenous Therapy with Chronic Immune Thrombocytopenia (ITP)

Assisted Administration Of Subcutaneous 5-Azacytidine to The Patient's Home. Significant Reduction Of Indirect Costs Incurred By Care Recipients and Unpaid Caregivers Together With a Total Adhesion To The Treatment Schedule and Same Safety

Platelet Kinetic Study (PKS) May Early Identify a Subset of Patients with Immune Thrombocytopenia (ITP) Probably Cured by Romiplostim. Two Years Follow-up

Efficacy and Tolerability of Pregabalin in Decreasing Pain Associated with High Dose of Imatinib in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase CML.

Phase II Study of Liposome Encapsulated Doxorubicin Citrate Complex, NPLD (Myocet™) in Myelofibrosis with Myeloid Metaplasia (MMM).

Correlation of JAK2 Mutation and PRV-1 and WT1 Transcript Amount in Myeloproliferative Disorders.

Successful Peripheral Blood Stem Cell (PBSC) Mobilisation with G-CSF in Patients with Chronic Myeloid Leukaemia Achieving Complete Cytogenetic Remission with Imatinib.

WT-1 Over-Expression Could Be Related to " High Metaplastic Index" in Myelofibrosis with Myeloid Metaplasia (MMM) Patients. A Preliminary Report.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only